NUTM1 and cancer: JQ1 is a potent competitive inhibitor of acetylation of lysine residues for BET, and it was initially proven to be effective in nuclear protein in testis (NUT) midline carcinoma (NMC), a cancer driven by the BRD4-NUT fusion protein18.